MRD-POSITIVE
Clinical trials for MRD-POSITIVE explained in plain language.
Never miss a new study
Get alerted when new MRD-POSITIVE trials appear
Sign up with your email to follow new studies for MRD-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CAR-T cells take on stubborn leukemia after transplant in new trial
Disease control Recruiting nowThis study compares two treatments for patients with B-cell acute lymphoblastic leukemia who still have small amounts of cancer cells (minimal residual disease) after a stem cell transplant. One group receives a single infusion of their own genetically modified immune cells (CAR-…
Matched conditions: MRD-POSITIVE
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for leukemia patients: drug targets hidden cancer cells after transplant
Disease control Recruiting nowThis phase 2 trial tests the drug inotuzumab ozogamicin in 42 adults with B-cell acute lymphoblastic leukemia who have minimal residual disease (MRD) after a stem cell transplant. MRD means a few cancer cells remain undetectable by standard tests but can cause relapse. The drug a…
Matched conditions: MRD-POSITIVE
Phase: PHASE2 • Sponsor: Sheng-Li Xue, MD • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC